(Q37217856)

19 August 2017

1 reference

title

Novel potential mechanisms for diabetic macular edema: leveraging new investigational approaches (English)

1 reference

19 August 2017

main subject

diabetic macular edema

1 reference

Thomas W Gardner

1

1 reference

19 August 2017

David A Antonetti

series ordinal

2

1 reference

19 August 2017

publication date

1 August 2008

1 reference

19 August 2017

published in

Current diabetes report

1 reference

19 August 2017

volume

8

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

263-269

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-008-0047-5

19 August 2017

exact match

0 references

cites work

Evaluation of the role of P-glycoprotein in the uptake of paroxetine, clozapine, phenytoin and carbamazapine by bovine retinal endothelial cells

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-008-0047-5

VEGF: a critical player in neurodegeneration

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-008-0047-5

Leukocyte-mediated endothelial cell injury and death in the diabetic retina

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-008-0047-5

Type of diabetes mellitus associated with diabetic retinitis

21 January 2018

1 reference

12 December 2020

Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology

1 reference

12 December 2020

Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema

1 reference

12 December 2020

Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells

1 reference

12 December 2020

Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study

1 reference

12 December 2020

Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy

1 reference

12 December 2020

A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema

1 reference

12 December 2020

Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier

1 reference

12 December 2020

The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes

1 reference

12 December 2020

TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function

1 reference

12 December 2020

Inflammation, stress, and diabetes

1 reference

12 December 2020

Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter

1 reference

12 December 2020

Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema

1 reference

12 December 2020

Ocular structure and function in an aged monkey with spontaneous diabetes mellitus

1 reference

12 December 2020

Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia

1 reference

12 December 2020

Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element

1 reference

12 December 2020

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

1 reference

12 December 2020

Retinal angiogenesis in development and disease

1 reference

12 December 2020

Vascular permeability in ocular disease and the role of tight junctions

1 reference

12 December 2020

Diabetic retinopathy: seeing beyond glucose-induced microvascular disease.

1 reference

12 December 2020

Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation

1 reference

12 December 2020

Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor

1 reference

12 December 2020

The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program

1 reference

12 December 2020

An extension of the Early Treatment Diabetic Retinopathy Study (ETDRS) system for grading of diabetic macular edema in the Astemizole Retinopathy Trial.

1 reference

12 December 2020

Diabetic retinopathy: more than meets the eye.

1 reference

12 December 2020

Occludin independently regulates permeability under hydrostatic pressure and cell division in retinal pigment epithelial cells

1 reference

12 December 2020

Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group

1 reference

12 December 2020

A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema

1 reference

12 December 2020

Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema

1 reference

12 December 2020

Expression of antiapoptotic and proapoptotic molecules in diabetic retinas

1 reference

12 December 2020

The fundamental plan of the retina

1 reference

12 December 2020

The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: baseline characteristics

1 reference

12 December 2020

Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail--chick transplantation chimeras

1 reference

12 December 2020

Role of NADPH oxidase in retinal vascular inflammation.

1 reference

12 December 2020

Thiazolidinediones and their fluid-related adverse effects: facts, fiction and putative management strategies.

1 reference

12 December 2020

Management of diabetic retinopathy: a systematic review

1 reference

12 December 2020

Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model

1 reference

12 December 2020

Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice

1 reference

12 December 2020

Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.

1 reference

12 December 2020

Correlation between intraretinal changes in diabetic macular oedema seen in fluorescein angiography and optical coherence tomography

1 reference

12 December 2020

The potential role of PKC beta in diabetic retinopathy and macular edema

1 reference

12 December 2020

The RAGE axis in early diabetic retinopathy

1 reference

12 December 2020

Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.

1 reference

12 December 2020

Diabetes reduces basal retinal insulin receptor signaling: reversal with systemic and local insulin

1 reference

12 December 2020

Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats

1 reference

12 December 2020

Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor

1 reference

12 December 2020

Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy

1 reference

12 December 2020

The Use of Intravitreal Etanercept in Diabetic Macular Oedema

1 reference

12 December 2020

Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation

1 reference

12 December 2020

Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor

1 reference

12 December 2020

Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial

1 reference

12 December 2020

Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin

1 reference

12 December 2020

Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium

1 reference

12 December 2020

Serum inflammatory markers in diabetic retinopathy

1 reference

12 December 2020

Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes

1 reference

12 December 2020

Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression

1 reference

12 December 2020

Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes.

1 reference

12 December 2020

Glial reactivity, an early feature of diabetic retinopathy.

1 reference

12 December 2020

Angiotensin and bradykinin: targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy

1 reference

12 December 2020

Antihistamines reverse blood-ocular barrier breakdown in experimental diabetes

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S11892-008-0047-5

Identifiers

DOI

1 reference

19 August 2017

1 reference